Subscribe or Manage Preferences
Continuing Education

Estimated time to complete activity: 1 hour

Date of initial release: February 11, 2014

Valid for CPE/CME/CE credit through: February 11, 2015

Target Audience
This activity was developed for managed care pharmacists and professionals who are involved in the care of patients with cancer or autoimmune disorders, and who manage insurance designs.

Learning Objectives
Upon completion of this activity, the participant will be able to:
  • Describe the current trends in the use of biologic therapies in oncology, rheumatology, inflammatory bowel disease, and multiple sclerosis
  • Discuss the challenges facing all stakeholders in optimizing value in the use of biologic therapies
  • Analyze issues around cost, quality, and access to care in the use of biologic therapies
  • Formulate biologic treatment options that maximize value by improving clinical outcomes and reducing disease burden on patients, families, and the healthcare system
Last modified: May 21, 2015
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology